Allograft renal rejection and chemokine polymorphism

Area of Science:

• Immunogenetics
• Transplantation immunology
• Molecular biology

Background:

• Chemokines and their receptors (CCR5, CCR2, MCP-1) are crucial for leukocyte recruitment in inflammation.
• Functional polymorphisms in these genes are associated with transplant rejection.
• Understanding these genetic variations is key to improving transplant success.

Purpose of the Study:

• To investigate the association between specific chemokine receptor gene polymorphisms and renal transplant rejection.
• To analyze CCR5-∆32, CCR5-59029-A/G, CCR2-V64I, and MCP-1 G/A (-2518) polymorphisms in renal transplant recipients and controls.

Main Methods:

• Genotyping of CCR5, CCR2, and MCP-1 polymorphisms in 173 renal transplant recipients and 169 healthy controls.
• Classification of recipients into HLA-identical (Group-1) and mismatched graft (Group-2) groups.
• Analysis of acute rejection episodes (ARs) and chronic allograft dysfunction (CAD) in relation to genotypes.

Main Results:

• No significant differences in genotypic or allelic frequencies were found between patients and controls, or between recipient groups.
• A significant association was observed between the CCR2-64I allele and a reduced risk of acute renal transplant rejection in HLA-identical recipients (Group-1).
• No significant association was found between the CCR2-64I polymorphism and chronic allograft dysfunction.

Conclusions:

• The CCR2-64I allele may play a protective role against acute rejection in HLA-identical renal transplant recipients.
• This finding contributes to the spectrum of immunogenetic factors influencing allograft survival.
• Further research is warranted to elucidate the precise mechanisms involved.